Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
2 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
3 Not yet recruiting Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
Condition: Antiplatelet Drugs
Interventions: Drug: Aspirin only;   Drug: No antiplatelet therapy
4 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
5 Recruiting Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Conditions: Cerebral Hemorrhage;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
6 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
7 Recruiting Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
Condition: Angina Pectoris
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
8 Recruiting Pharmacodynamic Study of Cilostazol in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Cilostazol;   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
9 Not yet recruiting REstart or STop Antithrombotic Randomised Trial in France
Condition: Cerebral Hemorrhage
Intervention: Drug: Clopidogrel or Aspirin and/or Dypyridamole
10 Not yet recruiting Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: ticagrelor
11 Recruiting ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
Condition: Coronary Artery Disease
Interventions: Drug: 1-month DAPT;   Drug: 12-month DAPT
12 Recruiting The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
Condition: Platelet Aggregation Onhibitors
Intervention: Drug: antiplatelet drugs - P2Y12 antagonists
13 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
Intervention:
14 Recruiting Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
15 Recruiting Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
Condition: Coronary Heart Disease
Intervention: Drug: antiplatelet agents
16 Recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
17 Not yet recruiting IU Health Krannert Personalized Medicine Study
Condition: Coronary Artery Disease
Intervention: Genetic: CYP2C19 genotyping
18 Not yet recruiting Dental Extractions in Patients Under Dual Antiplatelet Therapy
Condition: Blood Coagulation Disorders
Interventions: Device: HemCon Dental Dressing;   Device: Oxidized Cellulose Gauze
19 Recruiting Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
Condition: Aortic Valve Stenosis
Interventions: Drug: Ticagrelor alone;   Drug: Combination lysine acetylsalicylate - clopidogrel
20 Recruiting Antiplatelet Therapy Effect on Platelet Extracellular Vesicles in Acute Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.